KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aurinia Pharmaceuticals (AUPH) Other Accumulated Expenses (2016 - 2026)

Aurinia Pharmaceuticals filings provide 9 years of Other Accumulated Expenses readings, the most recent being $2.5 million for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses rose 61.99% to $2.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 million, a 61.99% increase, with the full-year FY2025 number at $2.5 million, up 61.99% from a year prior.
  • Other Accumulated Expenses hit $2.5 million in Q4 2025 for Aurinia Pharmaceuticals, down from $2.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $6.5 million in Q3 2021 to a low of $502000.0 in Q1 2022.
  • Median Other Accumulated Expenses over the past 5 years was $2.1 million (2022), compared with a mean of $2.2 million.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 88.79% in 2022 and later surged 294.22% in 2023.
  • Aurinia Pharmaceuticals' Other Accumulated Expenses stood at $4.4 million in 2021, then crashed by 54.31% to $2.0 million in 2022, then increased by 17.46% to $2.4 million in 2023, then tumbled by 35.89% to $1.5 million in 2024, then surged by 61.99% to $2.5 million in 2025.
  • The last three reported values for Other Accumulated Expenses were $2.5 million (Q4 2025), $2.5 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.